Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENVB | AMGN | BMY | VRTX | GILD |
| Company | Enveric Biosciences Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.3000 | 280.13 | 60.28 | 443.88 | 95.00 |
| High | 0.3000 | 283.50 | 60.59 | 446.98 | 96.70 |
| Low | 0.2700 | 279.97 | 58.74 | 438.01 | 93.81 |
| Last | 0.2769 | 280.30 | 58.76 | 440.68 | 93.85 |
| Change | -0.0284 | -2.65 | -1.84 | -3.20 | -1.50 |
| % Change | -9.30% | -0.94% | -3.04% | -0.72% | -1.57% |
| Volume | 510,765 | 2,735,291 | 9,231,210 | 1,159,606 | 7,405,271 |
| 20-Day Average Volume | 1,119,653 | 2,982,050 | 9,446,775 | 1,488,705 | 6,360,574 |
| Previous Close | 0.3053 | 282.95 | 60.60 | 443.88 | 95.35 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3636 | 268.14 | 57.10 | 418.21 | 92.03 |
| 20-Day Raw Stochastic | 2.60% | 87.90% | 62.80% | 86.05% | 64.94% |
| 20-Day Relative Strength | 37.41% | 54.85% | 56.22% | 53.30% | 56.21% |
| Weighted Alpha | -76.58 | -13.27 | +26.56 | +0.28 | +28.86 |
| Today's Opinion | 88% Sell | 56% Sell | 88% Buy | 64% Sell | 100% Buy |
| Previous Opinion | 80% Sell | 56% Sell | 88% Buy | 48% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 88% Sell | 80% Buy | 72% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.96% since 01/21/25 | +2.00% since 01/21/25 | +3.02% since 01/21/25 | +2.99% since 01/21/25 | +0.96% since 01/21/25 |
| Low | 0.2700 on 01/28/25 | 272.07 on 01/22/25 | 55.95 on 01/22/25 | 424.54 on 01/23/25 | 91.84 on 01/22/25 |
| High | 0.3500 on 01/22/25 | 283.50 on 01/28/25 | 61.10 on 01/27/25 | 447.72 on 01/27/25 | 96.70 on 01/28/25 |
| 1-Month | |||||
| %Chg | -20.20% since 12/27/24 | +6.72% since 12/27/24 | +1.87% since 12/27/24 | +7.81% since 12/27/24 | -0.28% since 12/27/24 |
| Low | 0.2700 on 01/28/25 | 257.05 on 01/06/25 | 54.81 on 01/13/25 | 397.24 on 01/13/25 | 88.57 on 01/10/25 |
| High | 0.5350 on 01/07/25 | 283.50 on 01/28/25 | 61.10 on 01/27/25 | 447.72 on 01/27/25 | 96.70 on 01/28/25 |
| 3-Month | |||||
| %Chg | -48.20% since 10/28/24 | -11.62% since 10/28/24 | +11.63% since 10/28/24 | -7.49% since 10/28/24 | +5.73% since 10/28/24 |
| Low | 0.2700 on 01/28/25 | 253.30 on 12/19/24 | 52.14 on 10/29/24 | 377.85 on 12/19/24 | 86.08 on 11/19/24 |
| High | 0.5500 on 10/29/24 | 328.25 on 11/08/24 | 61.10 on 01/27/25 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -41.12% since 07/26/24 | -16.29% since 07/26/24 | +16.47% since 07/26/24 | -11.02% since 07/26/24 | +21.87% since 07/26/24 |
| Low | 0.2700 on 01/28/25 | 253.30 on 12/19/24 | 46.22 on 08/08/24 | 377.85 on 12/19/24 | 72.43 on 08/12/24 |
| High | 0.7700 on 07/30/24 | 340.89 on 08/01/24 | 61.10 on 01/27/25 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,105 | 152,094,976 | 122,907,520 | 114,311,968 | 118,831,456 |
| Shares Outstanding, K | 10,170 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -17,290,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -2,080,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.62 | 0.56 | 0.45 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 11/14/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 03/24/25 | 02/04/25 | 02/06/25 | 02/10/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | N/A | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 51.00 | 0.00 | 21.01 |